Phase II Trial of Subcutaneous Interleukin-2, Subcutaneous Interferon-α, 5-Fluorouracil and Cis-retinoic Acid in the Treatment of Renal Cell Carcinoma: Final Results of Cancer Biotherapy Research Group 94-10

2002 ◽  
Vol 17 (2) ◽  
pp. 165-173 ◽  
Author(s):  
Gamini Soori ◽  
Robert O. Dillman ◽  
Michael C. Wiemann ◽  
James J. Stark ◽  
Fritz Tai ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Retinoic Acid ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Research Group ◽  
Renal Cell ◽  
Phase Ii Trial ◽  
Interleukin 2 ◽  
Interferon Α

A randomized phase II trial of Interleukin-2 in combination with four different doses of bryostatin in patients with renal cell carcinoma

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4608-4608
Author(s):  
A. C. Peterson ◽  
H. Harlin ◽  
T. Karrison ◽  
J. A. Knost ◽  
J. W. Kugler ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Trial ◽  
Interleukin 2 ◽  
Randomized Phase Ii ◽  
Different Doses

scholarly journals Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial

2006 ◽  
Vol 95 (9) ◽  
pp. 1167-1173 ◽  
Author(s):  
T Klatte ◽  
A Ittenson ◽  
F-W Röhl ◽  
M Ecke ◽  
E P Allhoff ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Trial ◽  
Interleukin 2
Sign in / Sign up

Export Citation Format

Share Document